Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
Evaluate the possibility of optimization of therapy with prostanoids (iloprost), in patients
with Fontaine's stage IIb severe chronic ischemia, both in patients eligible for surgery both
in patients for which it is only possible medical therapy